Equities

Daiken Medical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
7775:TYO

Daiken Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)480.00
  • Today's Change0.00 / 0.00%
  • Shares traded48.60k
  • 1 Year change-4.38%
  • Beta0.5349
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Company’s products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.

  • Revenue in JPY (TTM)10.17bn
  • Net income in JPY981.12m
  • Incorporated1968
  • Employees180.00
  • Location
    Daiken Medical Co Ltd2-6-2, AyuminoIZUMI-SHI 594-1157JapanJPN
  • Phone+81 725303150
  • Fax+81 662319902
  • Websitehttps://daiken-iki.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Yamashita Health Care Holdings Inc63.77bn412.00m9.11bn613.0021.530.998314.240.1429165.78165.7825,574.613,576.032.4314.255.39104,027,700.001.562.244.396.5313.5013.100.6430.89750.945--0.0032.954.76-0.05346.216.0343.356.79
Koken Ltd11.86bn885.29m9.68bn321.0010.550.67577.430.8162179.77179.772,408.462,805.840.54762.482.30--4.093.905.214.9545.4045.897.477.411.6823.740.295719.1510.173.1522.611.11-11.116.96
JTEC Corp1.93bn45.31m10.34bn76.00227.783.8850.245.377.697.69326.97450.770.56051.7126.4925,335,010.001.321.761.491.9961.0259.572.353.782.5519.790.15410.00-4.2213.39-69.7629.84-17.34--
Kainos Laboratories Inc5.46bn597.66m10.38bn157.0016.061.3514.861.90141.77141.771,294.101,688.390.61923.033.0734,748,430.006.787.128.129.3248.0951.5710.9611.493.45--0.071721.114.932.850.47879.976.9016.36
JMS Co Ltd66.09bn-224.00m11.06bn5.47k--0.26254.610.1673-9.15-9.152,695.911,703.210.76512.443.5412,084,290.00-0.36580.7427-0.53821.1022.7723.52-0.47810.88361.076.050.393671.626.833.56347.22-46.21-1.640.00
Create Medic Co Ltd13.57bn762.91m11.16bn1.00k13.190.61998.350.822487.6087.601,563.181,863.230.71481.824.9413,545,480.004.023.044.543.5844.6244.515.624.635.1741.710.045860.323.533.74445.963.0114.010.00
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn13.18bn538.00--0.522424.420.5363-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
OLBA Healthcare Holdings Inc124.48bn1.43bn13.22bn1.39k8.771.056.330.1062241.07241.0721,003.792,008.322.7716.234.8089,362,800.003.173.439.9111.3911.2611.491.151.220.958266.630.225530.513.492.61-4.6834.3828.7114.87
DVx Inc55.33bn308.75m13.28bn334.0041.821.4812.290.2429.4629.465,278.63831.732.2417.684.12165,663,400.001.252.643.286.459.6011.080.5581.281.23--0.002563.099.752.42137.18-12.33-2.4315.81
Daiken Medical Co Ltd10.17bn981.12m15.28bn180.0014.051.7912.441.5034.1534.15353.89267.890.90354.563.6456,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Seed Co Ltd33.57bn1.17bn16.25bn985.0013.850.87483.660.484238.7638.761,109.07613.830.642.357.4334,078,080.002.222.313.583.9445.1242.203.473.300.59286.620.575736.012.580.8892-44.3833.9912.644.56
Hoshi Iryo-Sanki Co Ltd15.45bn1.45bn17.17bn500.0010.830.812410.421.11463.58463.584,949.106,178.920.626224.075.8130,904,100.005.886.007.197.6149.7248.989.399.193.09--0.0015.312.196.784.2114.77-18.276.96
Medius Holdings Co Ltd295.20bn1.36bn18.66bn2.61k13.780.92024.910.063260.8660.8613,250.33911.802.3918.174.56112,928,700.001.101.654.356.0311.8212.070.45960.64920.924313.810.587328.5711.126.5322.307.6516.287.39
Techno Medica Co Ltd10.70bn1.04bn22.65bn244.0017.271.2419.952.12149.78149.781,542.982,077.510.64062.173.6943,841,880.006.226.587.167.7947.6849.669.7112.305.99--0.0040.22-3.680.1936-25.480.0825-40.566.77
Data as of Feb 13 2026. Currency figures normalised to Daiken Medical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

0.62%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 08 Jan 2026116.10k0.37%
Bessemer Investment Management LLCas of 31 Oct 202551.10k0.16%
Dimensional Fund Advisors Ltd.as of 30 Nov 20257.80k0.03%
Acadian Asset Management LLCas of 31 Jan 20266.50k0.02%
DFA Australia Ltd.as of 31 Dec 20255.23k0.02%
Amova Asset Management Co., Ltd.as of 16 Jun 20253.80k0.01%
SEI Investments Canada Co.as of 30 Jun 20253.40k0.01%
State Street Global Advisors (Japan) Co. Ltd.as of 05 Mar 20241.00k0.00%
Connor, Clark & Lunn Investment Management Ltd.as of 30 Jun 2025700.000.00%
Nomura Asset Management Co., Ltd.as of 29 Sep 2025600.000.00%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.